CIBC Private Wealth Group
BNTX icon

CIBC Private Wealth Group’s BioNTech BNTX Stock Holding History

CIBC Private Wealth Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$27.2K Hold
286
– – ﹤0.01% 2044
2025
Q3 		$28.2K Hold
286
– – ﹤0.01% 2031
2025
Q2 		$30.4K Hold
286
– – ﹤0.01% 1863
2025
Q1 		$24.8K Hold
286
– – ﹤0.01% 1918
2024
Q4 		$34.9K Hold
286
– – ﹤0.01% 1823
2024
Q3 		$34K Sell
286
-93
-25% -$8.55K ﹤0.01% 1916
2024
Q2 		$30.5K Buy
379
+4
+1% +$366 ﹤0.01% 1868
2024
Q1 		$34.9K Buy
+375
New +$36K ﹤0.01% 1816

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIBC Private Wealth Group's BNTX Position: Q4 2025 in Review

CIBC Private Wealth Group held its BioNTech (BNTX) position steady in Q4 2025 at 286 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

CIBC Private Wealth Group first reported a position in BNTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $34.9K in Q4 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • CIBC Private Wealth Group held 286 shares of BioNTech worth $27.2K as of Q4 2025.
  • CIBC Private Wealth Group left its BioNTech share count unchanged in Q4 2025.
  • BioNTech made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2044 holding.
  • CIBC Private Wealth Group first reported a position in BioNTech in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's BioNTech position peaked at $34.9K in Q4 2024.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.